Fresenius Takes Fiery Aim At Akorn's Ch. 11 Plan Disclosures
Global health care company Fresenius Kabi AG pilloried bankrupt Akorn Inc. Friday in an objection to the generic-drug maker's Delaware Chapter 11 disclosure, alleging major omissions, improper liability releases, violation of...To view the full article, register now.
Already a subscriber? Click here to view full article